Therapeutic Effect of Anti-VEGF for Age-Related Macular Degeneration in the Untreated Fellow Eye.
Hacer IsildakStephen G SchwartzHarry W FlynnPublished in: Case reports in ophthalmological medicine (2018)
Intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents have been reported to occasionally produce a therapeutic effect in the uninjected fellow eye. Here, three patients with bilateral neovascular age-related macular degeneration are presented. In all three patients, unilateral anti-VEGF injection resulted in bilateral reduction of macular thickness as measured by spectral domain optical coherence tomography.
Keyphrases
- age related macular degeneration
- optical coherence tomography
- growth factor
- endothelial cells
- vascular endothelial growth factor
- end stage renal disease
- ejection fraction
- newly diagnosed
- diabetic retinopathy
- chronic kidney disease
- ultrasound guided
- prognostic factors
- magnetic resonance imaging
- patient reported outcomes
- magnetic resonance
- platelet rich plasma